Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 291Carcinoma, Non-Small-Cell Lung 206Prostatic Neoplasms 158Lung Neoplasms 93Stomach Neoplasms 69Neoplasms 69Head and Neck Neoplasms 60Squamous Cell Carcinoma of Head and Neck 56Neoplasm Metastasis 50Esophageal Neoplasms 49Ovarian Neoplasms 39Pancreatic Neoplasms 26Sarcoma 23Carcinoma, Ovarian Epithelial 20Urinary Bladder Neoplasms 19Unspecified Adult Solid Tumor, Protocol Specific 19Breast Neoplasms, Male 17Adenocarcinoma Of Esophagus 17Parkinson Disease 4, Autosomal Dominant Lewy Body 16Esophageal Squamous Cell Carcinoma 16Adenocarcinoma of Lung 16Fallopian Tube Neoplasms 14Carcinoma, Squamous Cell 14Adenocarcinoma 12Melanoma 11Inflammatory Breast Neoplasms 11Uterine Cervical Neoplasms 9Triple Negative Breast Neoplasms 9Salivary Gland Neoplasms 8Endometrial Neoplasms 8

Interventions

Radiotherapy 3Chemotherapy, Adjuvant 3Magnetic Resonance Spectroscopy 2Letrozole 2Carboplatin 2gallium 68 PSMA-11 1fluciclovine F-18 1atamestane 1Zolpidem 1Venlafaxine Hydrochloride 1Trastuzumab 1Toremifene 1Thiotepa 1Tamoxifen 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Conformal 1Radiosurgery 1Radiation 1Proton Therapy 1Paclitaxel 1Melphalan 1Mass Spectrometry 1Indocyanine Green 1Immunohistochemistry 1Histocompatibility Testing 1Gene Expression Profiling 1Fulvestrant 1Fluorescent Antibody Technique 1Estrogen Receptor Modulators 1Drugs, Generic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Lobular × Docetaxel × Clear all
NCT00433589 2022-11-17

MINDACT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
6,600 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡